Table 2.
Device Information
| Device Model | # of Patients | |
|---|---|---|
| LVAD manufacturer (first) | Heartmate 2 | 44 (46.3%) |
| Heartmate 3 | 32 (33.7%) | |
| Heartware | 19 (20.0%) | |
| LVAD manufacturer (second) | Heartmate 3 | 1 device |
| ICD manufacturer | Medtronic | 48 (50.5%) |
| Boston Scientific/Guidant | 22 (23.2%) | |
| St. Jude Medical/Abbott Cardiovascular | 21 (22.1%) | |
| Biotronik | 4 (4.2%) | |
| ICD device class | Single chamber | 28 (29.5%) |
| Dual chamber | 17 (17.9%) | |
| Biventricular | 50 (52.6%) | |
| RV lead manufacturer | Medtronic | 44 (46.3%) |
| Boston Scientific/Guidant | 25 (26.3%) | |
| St. Jude Medical/Abbott Cardiovascular | 21 (22.1%) | |
| Biotronik | 5 (5.3%) | |
| Average RV lead age prior to LVAD | 4.4±3.7 years | |
| Average (median) days to interrogation | All devices | 78.9 (50) |
| Heartmate 2 | 78.1 (23) | |
| Heartmate 3 | 69.5 (49) | |
| Heartware | 96.5 (66) |